We recommend

  1. Leukocyte-specific DNA methylation biomarkers and their implication for pathological epigenetic analysis
    M. J. Dunnet et al., Epigenetics Communications, 2022
  2. The ASC2ESCALATE clinical trial is now enrolling for patients with CML. Find enrolling information today.
    Sponsored by Novartis Pharmaceuticals Corporation
  3. Clinical trial is enrolling patients with CML. Find enrolling ASC2ESCALATE clinical trial information today.
    Sponsored by Novartis Pharmaceuticals Corporation
  4. Connections between cross-tissue and intra-tissue biomarkers of aging biology in older adults
    R. Waziry et al., Epigenetics Communications, 2023
  5. Discover Oncology, an open access journal with 3.0 Impact Factor and 31 days to first decision. Find out how to publish your research.
    Discover Oncology, Springer Nature
  6. Comprehensive evaluation of the Infinium human MethylationEPIC v2 BeadChip
    Diljeet Kaur et al., Epigenetics Communications, 2023
Powered by
  • Targeting settings
  • Do not sell my personal information
  • Google Analytics settings
I consent to the use of Google Analytics and related cookies across the TrendMD network (widget, website, blog). Learn more